Mea Kākau: William Ramirez
Lā O Ka Hana: 20 Kepakemapa 2021
HōʻAno Hou I Ka Lā: 19 Kepakemapa 2024
Anonim
Management of Attention-Deficit Hyperactivity Disorder with a Focus on Pharmacogenetics
Wikiō: Management of Attention-Deficit Hyperactivity Disorder with a Focus on Pharmacogenetics

Anter

Ua hōʻike ʻia nā noiʻi i nā keiki a me nā ʻōpio me ka maʻi hyperactivity deficit attention-deficit (ADHD; ʻoi aku ka paʻakikī o ka nānā ʻana, ka mālama ʻana i nā hana, a me ka noho mālie a mālie paha ma mua o nā poʻe like like) ka poʻe i lawe i ka viloxazine e noʻonoʻo e pili ana i ka pepehi ʻana iā lākou iho ma mua o nā keiki. a me nā ʻōpio me ADHD i lawe ʻole i ka viloxazine.

ʻOiai ke lawe nei kāu keiki i ka viloxazine, pono ʻoe e nānā pono i kāna ʻano, keu hoʻi i ka hoʻomaka o ka mālama ʻana a i kēlā me kēia manawa e hoʻonui a hoʻemi ʻia paha kāna lāʻau. Hiki paha i kāu keiki ke ulu i nā ʻōuli koʻikoʻi loa, no laila he mea nui e hoʻolohe i kāna hana i kēlā me kēia lā. E noi i nā poʻe ʻē aʻe e hoʻolōʻihi i ka manawa me kāu keiki, e like me nā kaikaina, nā kaikuahine, a me nā kumu e haʻi iā ʻoe inā ʻike lākou i nā loli i ka hana a kāu keiki. Kāhea koke i ke kauka o kāu keiki inā ʻike kāu keiki i kekahi o kēia mau ʻōuli: hana ʻoi aku ka haʻahaʻa a huki ʻia paha ma mua o ka maʻamau. manaʻo kōkua ʻole, manaʻolana ʻole, a waiwai ʻole paha; kaumaha hou a i ʻole ke kaumaha paha; ke noʻonoʻo a kamaʻilio paha e pili ana i ka hōʻino a pepehi paha iā ia- a iā ia iho a i ʻole ke hoʻolālā a hoʻāʻo ʻana paha e hana pēlā. hopohopo nui loa; hoʻonāukiuki; hoʻouka weliweli; paʻakikī e hiamoe a hiamoe paha; ukiuki; hana kolohe a kolohe paha; hana me ka noʻonoʻo ʻole; hoʻonui loa i ka hana a kamaʻilio paha; pīhoihoi, pīhoihoi ʻole; a i ʻole nā ​​hoʻololi hou a kolohe paha i ka lawena.


E makemake ke kauka o kāu keiki e ʻike pinepine i kāu keiki ʻoiai ke lawe nei ʻo ia i ka viloxazine, keu hoʻi i ka hoʻomaka o kāna lapaʻau ʻana. E makemake paha ke kauka o kāu keiki e kamaʻilio pū me ʻoe a i ʻole kāu keiki ma ke kelepona mai kēlā me kēia manawa. E mālama pono i kāu keiki i nā manawa a pau no ke kipa ʻana i ke keʻena a i ʻole ke kamaʻilio kelepona ʻana me kāna kauka.

E kamaʻilio me kāu kauka e pili ana i nā pilikia o ka hāʻawi ʻana i viloxazine i kāu keiki, no ka hoʻohana ʻana i nā lāʻau ʻē aʻe no ka maʻi o kāu keiki, a me ka mālama ʻole ʻana i ke ʻano o kāu keiki.

Hoʻohana ʻia ʻo Viloxazine ma ke ʻano he mahele o kahi papahana lapaʻau e hoʻonui i ka hiki ke nānā a hoʻoliʻiliʻi i ka impulsiveness a me ka hyperactivity i nā keiki 6 a 17 mau makahiki me ka deficit hyperactivity maʻi (ADHD). Aia ʻo Viloxazine i loko o ka papa o nā lāʻau i kapa ʻia he mau mea hoʻopukapuka norepinephrine selective. Hana ia ma ka hoʻonui ʻana i nā pae o ka norepinephrine, kahi mea kūlohelohe i ka lolo e pono ai e kaohi i ka lawena.

Hele mai ʻo Viloxazine ma ke ʻano he capsule e lawe ma ka waha. Lawe ʻia ia i hoʻokahi manawa i ka lā me ka ʻai ʻole. Lawe iā viloxazine ma kahi o ka manawa like i kēlā me kēia lā. E hāhai pono i nā ʻōkuhi i kāu lepili kuhikuhi, a nīnau i kāu kauka a kauka paha e wehewehe i kahi ʻāpana āu i maopopo ʻole ai. E lawe pololei i ka viloxazine. Mai lawe i ka mea ʻoi aku a liʻiliʻi paha o ia mea a lawe pinepine iā ia ma mua o ka mea i kauoha ʻia e kāu kauka.


E ale i nā capsule holoʻokoʻa; mai hoʻokaʻawale, a nau aku, a hoka ʻole iā lākou.

Inā ʻaʻole hiki ke ale ʻia nā capsule, wehe i ka capsule a kāpīpī i nā mea i loko o kahi teaspoonful o ka ʻoma. E ale koke i nā hui a pau; mai nau i ka hui. E ale i ka hui i loko o ʻelua mau hola o ka hoʻohuihui ʻana. mai mālama i ka hui ʻana no ka hoʻohana ʻia i ka wā e hiki mai ana.

E hoʻomaka paha kāu kauka iā ʻoe ma kahi haʻahaʻa o ka viloxazine a hoʻonui i kāu lāʻau ma hope o 7 mau lā.

Hiki i ka Viloxazine ke kōkua i ka mālama ʻana i nā ʻōuli o ADHD akā ʻaʻole e hoʻōla i kēia ʻano. E hoʻomau i ka lawe ʻana i viloxazine ʻoiai inā maikaʻi ʻoe. Mai hōʻoki i ka lawe ʻana i ka viloxazine me ke kamaʻilio ʻole ʻana me kāu kauka.

E hāʻawi aku kāu kauka a kauka paha iā ʻoe i ka palapala ʻike hoʻomanawanui o ka mea hana (Kauka Lapaʻau) ke hoʻomaka ʻoe i ka lāʻau me viloxazine a i kēlā me kēia manawa e hoʻopiha hou i kāu kauka. E heluhelu pono i ka ʻike a nīnau i kāu kauka a kauka paha inā he nīnau kāu. Hiki iā ʻoe ke kipa aku i ka pūnaewele ʻo Food and Drug Administration (FDA) (http://www.fda.gov/Drugs) a i ʻole pūnaewele o ka mea hana e kiʻi i ka Medication Guide.


Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka lawe ʻana i viloxazine,

  • e haʻi i kāu kauka a me kāu kauka lāʻau inā he maʻi ʻoe i ka viloxazine, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i loko o nā capsule viloxazine. E noi i kāu kauka lāʻau a nānā i ke alakaʻi lāʻau no kahi papa inoa o nā mea hoʻohui.
  • e haʻi i kāu kauka inā lawe ʻoe i nā mea hoʻopāpā monoamine oxidase (MAO), e like me isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), safinamide (Xadago), selegiline (Eldepryl, Emsam, Zelapar), a me tranylcypromine (Parnate), a i ʻole ua hōʻoki ʻoe i ka lawe ʻana iā lākou i loko o 2 mau pule i hala. Eia kekahi, e haʻi i kāu kauka inā lawe ʻoe i ka alosetron (Lotronex), duloxetine (Cymbalta), ramelteon (Rozerem), tasimelteon (Hetlioz), tizanidine (Zanaflex), a i ʻole theophylline. E haʻi paha kāu kauka iā ʻoe ʻaʻole e lawe i ka viloxazine me kekahi o kēia mau lāʻau.
  • e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe. E haʻi pono i kekahi o kēia mau mea: atomoxetine (Strattera), avanafil (Stendra), buspirone, clozapine (Clozaril, Versacloz), conivaptan (Vaprisol), darifenacin (Enablex), darunavir (Prezista), desipramine (Norpramin), dextromethorphan loaʻa i loko o nā lāʻau lapaʻau he nui; i Nuedexta), everolimus (Afinitor), ibrutinib (Imbruvica), lomitapide (Juxtapid), lovastatin (Altoprev), lurasidone (Latuda), metoprolol, midazolam, naloxegol (Movantik), nebivolol (Bystolic) (Sular), nortriptyline (Pamelor), perphenazine, pirfenidone (Esbriet), risperidone (Perseris, Risperdal), saquinavir (Invirase), simvastatin (Flolipid, i Vytorin), sirolimus (Rapamune), tacrolimus (Prograf), tipranavir , tolterodine (Detrol), triazolam (Halcion), vardenafil (Levitra), a me venlafaxine (Pristiq). Nui paha nā lāʻau ʻē aʻe e launa pū paha me viloxazine, no laila e ʻike pono i kāu kauka e pili ana i nā lāʻau a pau āu e lawe nei, a ʻo nā mea ʻaʻole i ʻike ʻia ma kēia papa inoa. Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
  • e haʻi i kāu kauka inā ʻoe a i ʻole kekahi o kou ʻohana i loaʻa i ke kaumaha, bipolar maʻi (manic depressive maʻi; kahi ʻano e hoʻopuka ai i nā ʻāpana o ke kaumaha, nā ʻāpana o ka pīhoihoi, ka pīhoihoi ʻole a me nā ʻano ʻano ʻē aʻe ʻē aʻe), a i ʻole ua noʻonoʻo e pili ana iā hoʻāʻo e pepehi kanaka. E haʻi aku i kāu kauka inā loaʻa a i ʻole loaʻa i ke koko kiʻekiʻe, a i ʻole ka puʻuwai, ka ate a me nā maʻi puʻupaʻa.
  • e haʻi i kāu kauka inā hāpai ʻoe, hoʻolālā e hāpai, a i ʻole e hānai umauma ana. Inā hāpai ʻoe i ka lawe ʻana i viloxazine, e kāhea i kāu kauka.
  • pono ʻoe e ʻike ʻo ka viloxazine paha ʻoe e hiamoe ai. Mai hoʻokele i kahi kaʻa a hana i nā mīkini a ʻike ʻoe i ka hopena o kēia lāʻau iā ʻoe.
  • pono ʻoe e ʻike e hoʻohana ʻia ka viloxazine ma ke ʻano he ʻāpana o kahi papahana hoʻomaʻamaʻa huina no ADHD, i hiki ke hoʻopili ʻia me ka ʻōlelo aʻoaʻo a me ka ʻike kūikawā. E mālama pono i nā ʻōlelo aʻoaʻo a kāu kauka a me / a i ʻole therapist.
  • pono ʻoe e ʻike e hoʻonui paha kou kahe koko i kou wā e mālama ai me viloxazine. E nānā kāu kauka i kou kaomi koko i kou wā o ka lāʻau.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

E lawe i ka lāʻau i hala i kou wā e hoʻomanaʻo ai. Eia nō naʻe, inā kokoke i ka manawa no ka mahele hope aʻe, e lele i ka lāʻau i hala a hoʻomau i kāu papa hana maʻamau. Mai lawe i kahi lāʻau pālua e pani no kahi mea i hala.

ʻO Viloxazine paha ke kumu o nā hopena. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

  • nalo ʻai ʻole
  • luhi
  • nausea
  • ka luaʻi
  • ʻeha poʻo

Hiki paha i ka Viloxazine ke hoʻopili i ka waiwai kaumaha o nā keiki. E nānā pono paha kāu kauka i kāu keiki i ka wā o kāna mālama ʻana me viloxazine. E kamaʻilio me kāu kauka o kāu keiki e pili ana i ka makaʻu o ka hāʻawi ʻana i kēia lāʻau i kāu keiki.

Hiki iā Viloxazine ke hana i nā hopena ʻē aʻe. Kāhea i kāu kauka inā he pilikia ʻokoʻa kāu i ka lawe ʻana i kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

E mālama i kēia lāʻau i loko o ka pahu i komo ai, pani paʻa ʻia, a ʻaʻole hiki i nā kamaliʻi. E mālama iā ia i ka mahana wela o ka lumi a ma kahi o ka wela a me ka momona (ʻaʻole i ka lua.

He mea nui e mālama i nā lāʻau āpau mai ka maka a hiki i nā keiki e like me nā ipu (e like me nā minder pill i kēlā me kēia pule a me nā mea no nā kulu maka, nā kalima, nā pākuʻi, a me nā inhalers) ʻaʻole pale keiki a hiki i nā keiki ʻōpio ke wehe maʻalahi iā lākou. No ka pale ʻana i nā keiki ʻōpio mai ka lāʻau make, laka mau i nā pāpale palekana a kau koke i ka lāʻau i kahi palekana - kahi i luna a mamao a mai ko lākou alo a hiki. http://www.upandaway.org

Pono e hoʻolei ʻia nā lāʻau i koi ʻole ʻia i nā ala kūikawā e hōʻoia i ka hiki ʻole i nā holoholona, ​​nā keiki, a me nā poʻe ʻē aʻe ke hoʻopau iā lākou. Eia nō naʻe, ʻaʻole pono ʻoe e kaomi i kēia lāʻau i ka lua. Akā, ʻo ke ala ʻoi loa e hoʻolilo i kāu lāʻau i loko o kahi papahana hoʻihoʻi lāʻau. E kamaʻilio me kāu kauka lāʻau a kāhea paha i kāu ʻōpala a me nā hana hoʻopōʻaiapuni kūloko e aʻo e pili ana i nā papahana hoʻihoʻi i kou kaiāulu. E ʻike i ka pūnaewele palekana o kā FDA's Disposal of Medicines (http://goo.gl/c4Rm4p) no ka ʻike hou aku inā ʻaʻohe ou komo i kahi papahana hoʻihoʻi.

I ke kumu o ka overdose, e kāhea i ka helpline kaohi lāʻau make ma 1-800-222-1222. Loaʻa ka ʻike ma ka pūnaewele ma https://www.poisonhelp.org/help. Inā ua hina ka mea i hoʻomāinoino ʻia, loaʻa ka hopu ʻana, pilikia i ka hanu ʻana, a i ʻole hiki ʻole ke ala aʻe, e kāhea koke i nā lawelawe kūikawā ma 911.

Pākuʻi ʻia paha nā ʻōuli o ka overdose:

  • hiamoe
  • nalowale o ka ʻike
  • wikiwiki a i ʻole kuʻi puʻuwai puʻuwai
  • nāwaliwali o nā mākala

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. E nānā kāu kauka i kou kaʻe koko a me ka helu o ka puʻuwai a kauoha i kekahi mau hoʻokolohua lab e nānā i ka pane o kou kino i ka viloxazine.

Mai ʻae i kahi mea ʻē aʻe e lawe i kāu lāʻau. E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i ka hoʻopiha hou ʻana i kāu kuhikuhi.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

  • Qelbree®
Nānā Hou - 05/15/2021

NāʻAtikala IāʻOe

Kaposi sarcoma

Kaposi sarcoma

ʻO Kapo i arcoma (K ) kahi tumo maʻi ʻaʻai o ka mea hoʻopili.ʻO K ka hopena o ka maʻi me kahi gamma herpe viru i ʻike ʻia ʻo Kapo i arcoma-herpe viru (K HV), a i ʻole herpe viru kanaka 8 (HHV8). Aia i...
Bipolar kāna hana

Bipolar kāna hana

ʻO ka maʻi Bipolar kahi ʻano noʻonoʻo kahi ākea a koʻikoʻi paha i ke kanaka i ko lākou ʻano. Hiki ke hoʻololi i nā wā o ke kaumaha a me ke kaumaha me nā wā o ka pīhoihoi a me ka hana a i ʻole ke keʻa ...